To define the role of Irx4, a member of the Iroquois family of homeobox tra
nscription factors in mammalian heart development and function, we disrupte
d the murine Irx4 gene. Cardiac morphology in Irx4-deficient mice (designat
ed Irx4(Delta ex2/Delta ex2)) was normal during embryogenesis and in early
postnatal life. Adult Irx4(Delta ex2/Delta ex2) mice developed a cardiomyop
athy characterized by cardiac hypertrophy and impaired contractile function
. Prior to the development of cardiomyopathy, Irx4(Delta ex2/Delta ex2) hea
rts had abnormal ventricular gene expression: Irx4-deficient embryos exhibi
ted reduced ventricular expression of the basic helix-loop-helix transcript
ion factor eHand (Hand1), increased Irx2 expression, and ventricular induct
ion of an atrial chamber-specific transgene. In neonatal hearts, ventricula
r expression of atrial natriuretic factor and alpha -skeletal actin was mar
kedly increased. Several weeks subsequent to these changes in embryonic and
neonatal gene expression, increased expression of hypertrophic markers BNP
and beta -myosin heavy chain accompanied adult-onset cardiac hypertrophy.
Cardiac expression of Irx1, Irx2, and Irx5 may partially compensate for los
s of Irx4 function. We conclude that Irx4 is not sufficient for ventricular
chamber formation but is required far the establishment of some components
of a ventricle-specific gene expression program. In the absence of genes u
nder the control of Irx4, ventricular function deteriorates and cardiomyopa
thy ensues.